These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11172730

  • 1. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug.
    Erba F, Fiorucci L, Pascarella S, Menegatti E, Ascenzi P, Ascoli F.
    Biochem Pharmacol; 2001 Feb 01; 61(3):271-6. PubMed ID: 11172730
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gabexate mesylate inhibition of serine proteases: thermodynamic and computer-graphics analysis.
    Menegatti E, Bolognesi M, Scalia S, Bortolotti F, Guarneri M, Ascenzi P.
    J Pharm Sci; 1986 Dec 01; 75(12):1171-4. PubMed ID: 3104578
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of gabexate mesylate (FOY), a drug for serine proteinase-mediated diseases, on the nitric oxide pathway.
    Colasanti M, Persichini T, Venturini G, Menegatti E, Lauro GM, Ascenzi P.
    Biochem Biophys Res Commun; 1998 May 19; 246(2):453-6. PubMed ID: 9610382
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Polycationic peptides as inhibitors of mast cell serine proteases.
    Lundequist A, Juliano MA, Juliano L, Pejler G.
    Biochem Pharmacol; 2003 Apr 01; 65(7):1171-80. PubMed ID: 12663052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. pH dependence of bovine mast cell tryptase catalytic activity and of its inhibition by 4',6-diamidino-2-phenylindole.
    Fiorucci L, Erba F, Bolognesi M, Coletta M, Ascoli F.
    FEBS Lett; 1997 May 12; 408(1):85-8. PubMed ID: 9180274
    [Abstract] [Full Text] [Related]

  • 14. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.
    Hochstrasser K, Gebhard W, Albrecht G, Rasp G, Kastenbauer E.
    Eur Arch Otorhinolaryngol; 1993 May 12; 249(8):455-8. PubMed ID: 8442939
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system.
    Di Marco S, Priestle JP.
    Structure; 1997 Nov 15; 5(11):1465-74. PubMed ID: 9384562
    [Abstract] [Full Text] [Related]

  • 19. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition.
    Stubbs MT, Morenweiser R, Stürzebecher J, Bauer M, Bode W, Huber R, Piechottka GP, Matschiner G, Sommerhoff CP, Fritz H, Auerswald EA.
    J Biol Chem; 1997 Aug 08; 272(32):19931-7. PubMed ID: 9242660
    [Abstract] [Full Text] [Related]

  • 20. A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
    Gao HJ, Song Q, Lv FQ, Wang S, Wang YR, Luo YK, Mei XG, Tang J.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct 08; 35(5):707-711. PubMed ID: 26489626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.